| 000 | 01091 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250515034626.0 | ||
| 264 | 0 | _c20060830 | |
| 008 | 200608s 0 0 eng d | ||
| 022 | _a1468-1331 | ||
| 024 | 7 |
_a10.1111/j.1468-1331.2006.01555.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHolmøy, T | |
| 245 | 0 | 0 |
_aManagement of progressive multifocal leukoencephalopathy associated with natalizumab--possibilities and responsibility. _h[electronic resource] |
| 260 |
_bEuropean journal of neurology _cAug 2006 |
||
| 300 |
_ae2 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadverse effects |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIntegrin alpha4 _ximmunology |
| 650 | 0 | 4 |
_aLeukoencephalopathy, Progressive Multifocal _xetiology |
| 650 | 0 | 4 | _aNatalizumab |
| 700 | 1 | _aHestvik, A L K | |
| 700 | 1 | _aVartdal, F | |
| 773 | 0 |
_tEuropean journal of neurology _gvol. 13 _gno. 8 _gp. e2 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1468-1331.2006.01555.x _zAvailable from publisher's website |
| 999 |
_c16468089 _d16468089 |
||